Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Postma

Showing results (41-50 of 135) with videos related to

Pageof 14
Sort By:
Sexually Transmitted Infections|October 24, 2003
A population based dynamic approach for estimating the cost effectiveness of screening for Chlamydia trachomatisR Welte, M Kretzschmar, J A R van den Hoek, et al.
AIDS Care|February 15, 2001
Socio-economic aspects of extended STD screening in pregnancyM J Postma, J C Jager, L T de Jong-van den Berg
Vaccine|October 24, 2013
RSV vaccine in development: assessing the potential cost-effectiveness in the Dutch elderly populationM J Meijboom, K B Pouwels, W Luytjes, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 1, 2008
The value of ProMED-mail for the Early Warning Committee in the Netherlands: more specific approach recommendedM E Zeldenrust, J C Rahamat-Langendoen, M J Postma, et al.
Nederlands Tijdschrift Voor Geneeskunde|June 26, 2003
[Splenectomy and pneumococcal vaccination]M J Postma, M A Heijnen, R de Vries, et al.
COPD|July 13, 2013
COPD in the working age population: the economic impact on both patients and governmentJ F M van Boven, S Vegter, T van der Molen, et al.
AIDS (London, England)|November 1, 1990
AIDS impact scenarios: questions for the years to comeH C Jager, M J Postma, R Leidl, et al.
Sexually Transmitted Infections|March 2, 2002
Comparing cost effectiveness of screening women for Chlamydia trachomatis in systematic and opportunistic approachesM J Postma, R Welte, J A R van den Hoek, et al.
Vaccine|September 14, 2019
Cost-effectiveness analysis on elderly pneumococcal vaccination in the Netherlands: Challenging the Dutch Health Council's adviceF Zeevat, J van der Schans, W G Boersma, et al.
Vaccine|September 25, 2001
Health economics of a hexavalent meningococcal outer-membrane vesicle vaccine in children: potential impact of introduction in the Dutch vaccination programJ M Bos, H C Rümke, R Welte, et al.
Pageof 14

Showing results (41-50 of 135) with videos related to

Sort By:
Pageof 14
Sexually Transmitted Infections|October 24, 2003
A population based dynamic approach for estimating the cost effectiveness of screening for Chlamydia trachomatisR Welte, M Kretzschmar, J A R van den Hoek, et al.
AIDS Care|February 15, 2001
Socio-economic aspects of extended STD screening in pregnancyM J Postma, J C Jager, L T de Jong-van den Berg
Vaccine|October 24, 2013
RSV vaccine in development: assessing the potential cost-effectiveness in the Dutch elderly populationM J Meijboom, K B Pouwels, W Luytjes, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 1, 2008
The value of ProMED-mail for the Early Warning Committee in the Netherlands: more specific approach recommendedM E Zeldenrust, J C Rahamat-Langendoen, M J Postma, et al.
Nederlands Tijdschrift Voor Geneeskunde|June 26, 2003
[Splenectomy and pneumococcal vaccination]M J Postma, M A Heijnen, R de Vries, et al.
COPD|July 13, 2013
COPD in the working age population: the economic impact on both patients and governmentJ F M van Boven, S Vegter, T van der Molen, et al.
AIDS (London, England)|November 1, 1990
AIDS impact scenarios: questions for the years to comeH C Jager, M J Postma, R Leidl, et al.
Sexually Transmitted Infections|March 2, 2002
Comparing cost effectiveness of screening women for Chlamydia trachomatis in systematic and opportunistic approachesM J Postma, R Welte, J A R van den Hoek, et al.
Vaccine|September 14, 2019
Cost-effectiveness analysis on elderly pneumococcal vaccination in the Netherlands: Challenging the Dutch Health Council's adviceF Zeevat, J van der Schans, W G Boersma, et al.
Vaccine|September 25, 2001
Health economics of a hexavalent meningococcal outer-membrane vesicle vaccine in children: potential impact of introduction in the Dutch vaccination programJ M Bos, H C Rümke, R Welte, et al.
Pageof 14